Tom van Wijk is a principal Scientist with over 20 years of experience in pharmaceutical analysis. Working at former Solvay Pharmaceuticals in early and late phase chemical and pharmaceutical development and currently supporting established marketed products at Abbott Healthcare Products in the Analytical Science and Technology Department.
Specialized in small molecule impurity profiling, mass spectrometry and method development for the active materials as well as the formulated products.
One of his key interests is developing applications and strategies to control trace levels of potential mutagenic impurities in pharmaceutical products.
Received his PhD from the Faculty of Pharmaceutical Sciences at the Utrecht University in November 2016.